This week will be important for several newly listed companies as their shareholder lock-in periods come to an end. According to Nuvama Alternative & Quantitative Research, eight companies will see shares worth more than ₹6,500 crore becoming eligible for trade. The end of a lock-in period does not mean shareholders will sell immediately, but it increases the supply of shares that can enter the market.
Pine Labs will experience two separate lock-in releases.
The stock continues to trade above its IPO price.
Lenskart will see 40.7 million shares (2%) released on December 8 as its one-month lock-in ends. The value of these shares is about ₹1,701 crore. The stock has held above its IPO price since listing.
Scoda Tubes will witness one of the largest unlocks in percentage terms.
Around 32.2 million shares, or 54% of total equity, will be eligible for trade. This block is worth ₹520 crore based on the latest closing price.
About 6.8 million shares (20%) of Dharmaj Crop Guard will unlock as its one-and-a-half-year lock-in ends. The block is valued at ₹140 crore, and the stock is currently at its IPO price.
The company will see 54 lakh shares worth ₹140 crore become tradable on December 8. Its stock is trading comfortably above issue price.
Groww’s parent company will see 149.2 million shares (2%) unlock on December 10, valued at ₹2,252 crore. Despite recent volatility, the stock remains well above its IPO price.
Kronox Lab Sciences will see 7.8 million shares (21%) worth ₹108 crore open for trade on December 10 as its extended lock-in ends.
Anthem will have lock-ins ending twice:
Its stock trades 15% above the IPO issue price.
With eight companies facing lock-in expiries this week, market participants will closely track any impact on share prices. While lock-ins increase supply, actual market reaction depends on investor sentiment, liquidity and company fundamentals.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.
Published on: Dec 9, 2025, 10:12 AM IST
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
